This website is intended for healthcare professionals

02 May 2022 02 May 2022

Volume 4 | Issue 5

ISSN (Print): 2631-8385

ISSN (Online): 2631-8393

Updates

The National Institute of Health and Care Excellence (NICE) has recommended an innovative and potentially life-extending drug for treating people with a specific gene mutation of advanced non-small-cell lung cancer (NSCLC), which will be available to patients on 14 April 2022..

More from this issue

Drug breakdown: Indapamide

Causes and treatment of urge incontinence in women

Challenges in prescribing practice

The dangers of online pharmacies

Calculating osmolarities of peripheral infusions to avoid thrombophlebitis

Calculation Skills

What is the value of supplementary prescribing in the 2020s? A dietitian's perspective

Association for Prescribers Special

Medication management for patients with Parkinson's: the impact of a nurse specialist and non-medical prescribing in the hospital setting

Association for Prescribers Special

Seasonal asthma: should it be managed differently?

Better Practice

Insulin for diabetes: 100 years of therapy

Calculating osmolarities of peripheral infusions to avoid thrombophlebitis: answers

Calculation Skills